HealthEquity (NASDAQ:HQY) Sets New 12-Month High – What’s Next?

HealthEquity, Inc. (NASDAQ:HQY) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $89.30 and last traded at $89.07, with a volume of 195192 shares trading hands. The stock had previously closed at $86.95.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Barrington Research restated an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America dropped their price target on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, HealthEquity has an average rating of “Buy” and a consensus target price of $103.83.

HealthEquity Stock Down 0.8 %

The firm has a market capitalization of $8.49 billion, a P/E ratio of 81.63, a PEG ratio of 1.36 and a beta of 0.52. The firm’s 50 day moving average is $82.36 and its two-hundred day moving average is $80.19. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. Research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

A number of institutional investors have recently bought and sold shares of HQY. Norden Group LLC acquired a new stake in HealthEquity during the 1st quarter valued at approximately $391,000. BNP Paribas Financial Markets grew its stake in HealthEquity by 15.3% during the first quarter. BNP Paribas Financial Markets now owns 49,286 shares of the company’s stock worth $4,023,000 after purchasing an additional 6,536 shares during the period. Janney Montgomery Scott LLC lifted its stake in HealthEquity by 27.4% in the first quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock valued at $324,000 after buying an additional 855 shares during the period. Fidelis Capital Partners LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at $42,000. Finally, Texas Permanent School Fund Corp lifted its position in shares of HealthEquity by 1.5% during the 1st quarter. Texas Permanent School Fund Corp now owns 75,092 shares of the company’s stock valued at $6,130,000 after acquiring an additional 1,121 shares during the period. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.